BioSpace News Archive

Align Technology, Inc. announced that it has entered into a new accelerated stock repurchase agreement with Goldman Sachs & Co. LLC, to repurchase $200 million of Align’s common stock under Align’s $1.0 billion stock repurchase program announced on May 13, 2021.

KBI Biopharma, Inc. (KBI) and Selexis SA (Selexis) today announced that Abdelaziz Toumi, Ph.D., will begin serving as the companies’ Chief Business Officer.

ZOLL, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that its TherOx SuperSaturated Oxygen (SSO2) Therapy has been awarded a group purchasing agreement for Diagnostic and Interventional Cardiology Catheters (DIC) with Premier, Inc., effective as of July 1, 2022.

ADC Therapeutics SA (NYSE: ADCT) today announced that it will host a conference call and live webcast on Tuesday, November 8, 2022 at 8:30 a.m. ET to report financial results for the third quarter 2022 and provide business updates.

Aulos Bioscience today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for AU-007, a monoclonal antibody computationally designed by Biolojic Design.

Lineage Cell Therapeutics, Inc. announced today that Jill Howe will join as the Company’s Chief Financial Officer, effective November 14, 2022.

Nuvo Pharmaceuticals Inc. today announced it expects to release its third quarter 2022 financial results before markets open on Monday, November 14, 2022.

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has entered into a definitive agreement to acquire The Binding Site Group (“The Binding Site”).

Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics, recently announced the launch of the Podiatry Board Review Challenge, a new professional educational resource.

Mosaic ImmunoEngineering today announced that two research grants totaling $4.3 million from the National Cancer Institute (NCI) were awarded to the Company’s collaborating scientists and their respective academic institutions.